CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project explores the use of endocannabinoids as a non-addictive treatment for migraines. By investigating the effects of specific enzyme inhibitors and cannabinoid compounds, it aims to enhance pain relief mechanisms and provide safer alternatives to traditional migraine medications.
Migraine is a common multifaceted neurovascular disease.
Traditional medications have limitations and even newer CGRP monoclonal antibodies only effectively treat 50% of patients.
Instead of using highly addictive painkillers, such as opioids, there is a great need for alternative, effective and safe medications.
Despite psychoactive side-effects of cannabis, its derivative compounds (cannabinoids) have emerged as a new class of analgesic and anti-migraine agents.
Indeed, the frequency of migrai…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
United States, Iowa City
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
